Molecular interactions and inhibition of the SARS-CoV-2 main protease by a thiadiazolidinone derivative.
Proteins
; 90(11): 1896-1907, 2022 11.
Article
in English
| MEDLINE | ID: covidwho-1844225
ABSTRACT
We report molecular interactions and inhibition of the main protease (MPro ) of SARS-CoV-2, a key enzyme involved in the viral life cycle. By using a thiadiazolidinone (TDZD) derivative as a chemical probe, we explore the conformational dynamics of MPro via docking protocols and molecular dynamics simulations in all-atom detail. We reveal the local and global dynamics of MPro in the presence of this inhibitor and confirm the inhibition of the enzyme with an IC50 value of 1.39 ± 0.22 µM, which is comparable to other known inhibitors of this enzyme.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Azoles
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
English
Journal:
Proteins
Journal subject:
Biochemistry
Year:
2022
Document Type:
Article
Affiliation country:
Prot.26385
Similar
MEDLINE
...
LILACS
LIS